Acessibilidade / Reportar erro

Chagasic infection among blood donors in Brazil: an integrative review

ABSTRACT

Based on the literature, this work aimed to discuss infection by Chagas disease among blood donors in Brazil. Studies on the prevalence of Trypanosoma cruzi infection in donors or candidates for blood donation in Brazil are important. The prevalence of infection appears to be a sensitive indicator and can be a true marker of the risk of the transmission of Chagas disease by blood transfusion. Moreover, it serves as a marker of the level of transmission of the disease in a region, as well as a tool to characterize the epidemiological profile of individuals affected by the disease. The present study is an integrative review of the literature on chagasic infection among blood donors. An evaluation of the literature identified the epidemiological profile of blood donors infected by T. cruzi, which is characterized in general as men, over 30 years old, with a low level of schooling, low income and mainly coming from rural areas.

Keywords:
Chagas disease; Trypanosoma cruzi; Blood donor; Blood transfusion; Brazil

Introduction

The American trypanosomiasis, also known as Chagas disease, is an important endemic parasitic disease and a medical and social problem in Brazil and in several other Latin American countries with impact both on the economy and on public health. Trypanosoma cruzi is an obligate intracellular pathogen and the etiologic agent of Chagas disease.11 Lopes PD, Ramos EL, Gomez HC, Ferreira GL, Rezende OK. Prevalence of Chagas disease among blood donor candidates in Triangulo Mineiro, Minas Gerais State, Brazil. Rev Inst Med Trop Sao Paulo. 2015;57(6):461-5.

The infection of humans and other vertebrates, such as rodents, carnivores and primates, occurs primarily by the contact of the skin and mucosa of the vertebrate host with the stools of the triatomine contaminated by T. cruzi. However, there are other forms of transmission, such as by blood transfusion, congenital, laboratory accidents, organ transplantation and ingestion.22 Ferreira JC, Costa PI, Buainain A, Rosa JA. Seropositivity for Chagas disease among blood donors in Araraquara São Paulo State, from 2004 to 2008. Rev Soc Bras Med Trop. 2011;44(1):110-2.

The World Health Organization (WHO) initiatives in partnership with Latin American governments have led to the control of vectorial transmission of Chagas disease by the main vector, Triatoma infestans, in several endemic areas by preventive measures to avoid the presence of triatomines in residences. With the control of natural transmission by means of eradication of the vector in different endemic countries, blood transfusion became the main mechanism of dissemination of Chagas disease in these countries during the 1980s and 90s.33 Lima LM, Alves NP, Barbosa VD, Pimenta GA, Moraes-Souza H, Martins PR. Prevalence of Chagas disease in blood donors at the Uberaba Regional Blood Center Brazil, from 1995 to 2009. Rev Soc Bras Med Trop. 2012;45(6):723-6.

Thus, another measure to control the endemic of Chagas disease in the country was the creation of the Southern Cone Initiative in 1991. This project established that in parallel to the fight against T. infestans, another objective would be to reduce and eliminate transmission by blood transfusion by strengthening the blood bank network and consequently the effective screening of blood donors. These preventive measures have contributed positively to the increased safety of blood transfusions in Brazil.44 Melo AS, Lorena VM, Moraes AB, Pinto MB, Leão SC, Soares AK, et al. The prevalence of chagasic infection among blood donors in the State of Pernambuco Brazil. Braz J Hematol Hemother. 2009;31(2):69-73.

The risk of the patient becoming infected when receiving a unit of blood from a chagasic donor is still variable. In regions with high vectorial transmission rates and a large number of infected individuals with high parasitic loads, such as Santa Cruz in Bolivia, blood transfusions account for 49% of the cases. In countries with low rates of natural transmission, such as, Argentina, Brazil, Chile and Uruguay, these rates are between 12% and 18% and the risk is even lower in non-endemic countries.55 Ferreira-Silva MM. Control of transfusional transmission. Rev Soc Bras Med Trop. 2011;44(Suppl. 2):64-7.

Studies on the prevalence of T. cruzi infection in donors or candidates for blood donation in Brazil are important. The prevalence of infection appears to be a sensitive indicator, and can be a true marker of the risk of Chagas disease transmission by blood transfusion. Moreover, it serves as a marker of the level of transmission of the disease in a region, as well as a tool to characterize the epidemiological profile of affected individuals. Thus, based on the literature, this study aims to discuss Chagas disease infection among blood donors in Brazil.

Methods

The present study is an integrative review of scientific publications on chagasic infection among blood donors in Brazil. The purpose of the research was to summarize the studies published in this field of interest in order to identify the topics addressed, to analyze the object of the study from the perspective of several authors and to identify their multiple determinants.

The integrative review is a type of research that presents a comprehensive methodological approach, as it allows an advanced analysis of available literature, discussions about methods and results of research, and reflections on the performance of other researchers. The main objective of this study was to obtain a broad understanding of a given phenomenon based on previously published studies.66 Nascimento IC, Araújo MS, Brito MD, Oliveira JG. Care of the nursing team in the pediatric emergency: Integrative review. Sanare. 2017;16(1):90-9.

Based on these definitions, published thematic studies about chagasic infection among blood donors in Brazil were identified. The literature search was conducted during the months of August thru December 2017 in the Virtual Health Library (VHL) database, which is an open access operational platform for technical cooperation of the Pan American Health Organization (PAHO). This platform is established as a site for the integration of health information sources to promote democratization and broader access to scientific and technical health information in Latin America and the Caribbean.

The search descriptors consisted of the following terms: “Chagas disease”, “Blood donors” and “Brazil”, using the Boolean operator “and” between each descriptor in order to find a greater number of publications on the subject. Ninety-two articles were identified by searching with the descriptor “Chagas Disease and Blood Donors and Brazil”. Inclusion and exclusion criteria were applied using the VHL platform filters.

The inclusion criteria were as follows: full articles published between 1997 and 2017, which are available electronically in the databases MEDLINE, LILACS and the State Secretariat of Health of São Paulo in Portuguese and English. The articles should have Chagas disease, blood donors, T. cruzi, blood banks, serological tests, blood transfusion, blood, prevalence and blood safety as the main subjects.

The exclusion criteria included articles prior to 1997, incomplete or unavailable articles, opinions and publications that do not refer to the main subjects. As a result 18 articles were identified, two of which were discarded because the articles did not follow the proposed methodology giving a total of 16 articles. Two more articles published in 2016 and 2017 were added to improve the discussion about this theme.

The selected articles were analyzed according to the information contained in the abstracts and subsequently each one was read in full. Thus, the main data that contained relevant information for analysis were extracted.

Results

After a careful reading, 18 articles were identified that met the inclusion and exclusion criteria. The selected articles were included in Table 1.

Table 1
Characterization of articles organized by title, authors, year, journal, type of study, aim, results and conclusions.

Discussion

Risk factors associated with chagasic infection in humans in Brazil

Five articles reported that there are several main sources of risk for the development of chagasic infection directly related to the Brazilian population. The presence of triatomines in residences is considered one of the major risk factors for Chagas disease in humans as well as close contact between humans and animals in endemic areas, which may be an abundant source of blood for triatomines, maintaining the peridomiciliary cycle of T. cruzi. Precarious conditions of dwelling, health and subsistence infrastructure in the ecosystems, where vectors are abundant are preponderant factors for the establishment of Chagas disease.77 Moura JF, Borges PJ, Costa J, Zauza PL, Rosa FM. On the possibility of autochthonous Chagas disease in Roraima, Amazon region, Brazil, 2000–2001. Rev Inst Med Trop S Paulo. 2005;47(1):45-4.

Aspects such as low monthly family income and agriculture as a profession are also associated with Chagas disease, as well as the process of migration from rural areas to urban areas.88 de Oliveira-Marques DS, Bonametti AM, Matsuo T, Gregori Junior F. The epidemiologic profile and prevalence of cardiopathy in Trypanosoma cruzi infected blood donor candidates, Londrina, Paraná, Brazil. Rev Inst Med Trop Sao Paulo. 2005;47(6):321-6. In addition, a family history of Chagas disease is an important factor since it is a good indicator of previous coexistence with the triatomine vector. The possibility of congenital transmission should be considered in cases where mothers are carriers of Chagas disease.99 Silva FM, Pereira GA, Lages S, Moraes SH. Socioepidemiological screening of serologically ineligible blood donors due to Chagas disease for the definition of inconclusive cases. Mem Inst Oswaldo Cruz. 2010;105(6):800-5.

The risk of Chagas disease transmission by blood transfusion is dependent on factors such as the presence of the parasite in the blood or transfused component, type and number of infected products transfused, immunological status of the recipient, level of donor serological coverage, and sensitivity of the serological tests used in donor selection. After transmission, the chagasic infection in the recipient is generally asymptomatic with rare acute forms being manifested mainly in immunosuppressed patients.55 Ferreira-Silva MM. Control of transfusional transmission. Rev Soc Bras Med Trop. 2011;44(Suppl. 2):64-7.

On the other hand, other mechanisms directly dependent on the enzootic cycle of transmission have become more important in Brazil, such as extra-domiciliar vectorial transmission in some cases associated with extractive activities, vector home transmission by visitors and also by ingestion, with an increasing number of cases of acute Chagas disease especially in the Amazon region.1010 Silveira AC. New challenges and the future of control. Rev Soc Bras Med Trop. 2011;44(Suppl. 2):122-4.

Diagnosis of Chagas disease in blood banks

According to the literature, the methodology applied for the screening of Chagas disease in blood donors should employ tests that are simple, specific, sensitive and low cost, and each donation should be submitted to at least two tests using different methods. The methods designed to detect T. cruzi antigens have low sensitivity because the parasitemia level is low or non-existent in individuals with chronic infections. The classical assays such as complement fixation, indirect immunofluorescence assay and reverse passive hemagglutination assay were commonly used in blood banks.1111 Hamerschlak N, Pasternak J, Amato NV, de Carvalho MB, Guerra CS, Coscina AL, et al. Chagas’ disease: an algorithm for donor screening and positive donor counseling. Rev Soc Bras Med Trop. 1997;30(3):205-9.

However, with the growing development of biotechnology, the serological tests used in blood banks were redesigned to have high sensitivity. Consequently, these tests improved blood transfusion quality and there was an improvement in specificity. Thus, there was a decrease in blood collection indexes from serological screening tests.1212 Salles NA, Sabino EC, Barreto CC, Barreto AM, Otani MM, Chamone DF. The discarding of blood units and the prevalence of infectious diseases in donors at the Pro-Blood Foundation/Blood Center of São Paulo, São Paulo, Brazil. Rev Panam Salud Publica. 2003;13(2–3):111-6.

The laboratory diagnosis is challenging both in the acute and chronic phases of T. cruzi infection despite the development of new techniques. The diagnosis is usually based on serological assays, as the direct detection of parasites is difficult even in modern molecular techniques such as polymerase chain reaction (PCR) because of low levels or absence of parasitemia. The proof of the diagnosis of Chagas disease is difficult, because of the lack of widely available and validated confirmatory tests and thus a large amount of inconclusive blood bank results are generated.1313 Sabino EC, Salles NA, Sarr M, Barreto AM, Oikawa M, Oliveira CD, et al. Enhanced classification of chagas serological results at 3 large blood centers in Brazil. Transfusion. 2010;50(12):2628-37.

The kits used for the diagnosis of Chagas disease use T. cruzi antigens obtained from strains and various forms of the parasite. The antibodies that react with these antigens can react with antigens from other pathologies such as Leishmania sp. conferring cross-reactions. This decreases the specificity of diagnostic tests for Chagas disease, which may be the cause of the inconclusive results found. This problem would be solved if the tests used specific antigens present in the most diverse strains and forms of T. cruzi.22 Ferreira JC, Costa PI, Buainain A, Rosa JA. Seropositivity for Chagas disease among blood donors in Araraquara São Paulo State, from 2004 to 2008. Rev Soc Bras Med Trop. 2011;44(1):110-2.

In the face of the evidence that most of these inconclusive reactions translate into failed serological tests, these tests cause many healthy individuals to be considered as having a serious illness, which causes social and psychological difficulties to the excluded donor. In addition, it causes unnecessary discard of blood units and significant financial losses for the country. In this regard, studies are needed to find new measures to improve the accuracy of serological tests, which would consequently reduce the unnecessary disposal of blood bags.44 Melo AS, Lorena VM, Moraes AB, Pinto MB, Leão SC, Soares AK, et al. The prevalence of chagasic infection among blood donors in the State of Pernambuco Brazil. Braz J Hematol Hemother. 2009;31(2):69-73.

Epidemiological profile of Chagas disease in blood donors in Brazil

According to the detailed analysis of the articles, one of the most significant considerations is that the majority of blood donors seropositive for Chagas disease in Brazil present a specific epidemiological profile. They are generally men, over 30 years old, with a low level of schooling, low income and coming mainly from rural areas and living in urban centers (Figure 1).11 Lopes PD, Ramos EL, Gomez HC, Ferreira GL, Rezende OK. Prevalence of Chagas disease among blood donor candidates in Triangulo Mineiro, Minas Gerais State, Brazil. Rev Inst Med Trop Sao Paulo. 2015;57(6):461-5.44 Melo AS, Lorena VM, Moraes AB, Pinto MB, Leão SC, Soares AK, et al. The prevalence of chagasic infection among blood donors in the State of Pernambuco Brazil. Braz J Hematol Hemother. 2009;31(2):69-73.,88 de Oliveira-Marques DS, Bonametti AM, Matsuo T, Gregori Junior F. The epidemiologic profile and prevalence of cardiopathy in Trypanosoma cruzi infected blood donor candidates, Londrina, Paraná, Brazil. Rev Inst Med Trop Sao Paulo. 2005;47(6):321-6.,1313 Sabino EC, Salles NA, Sarr M, Barreto AM, Oikawa M, Oliveira CD, et al. Enhanced classification of chagas serological results at 3 large blood centers in Brazil. Transfusion. 2010;50(12):2628-37.1616 Slavov SN, Otaguiri KK, Pinto MT, Valente VB, Ubiali EM, Covas DT, et al. Prevalence of Trypanosoma cruzi antibodies in blood donors from the Sao Paulo State Brazil, between 2012 and 2014. J Infect Dev Ctries. 2017;11(3):277-81.

Figure 1
Epidemiological profile of Chagas disease in blood donors in Brazil.

A study performed in the state of Ceará corroborated with the data presented, where it is noticed that the male contribution to the reactivity for Chagas disease was significantly higher than women.1414 Sobreira AC, Gomes FV, Silva MA, Oliveira MF. Chagasic infection prevalence in blood donors at the Regional Blood Donation Center of Iguatu. Rev Soc Bras Med Trop. 2001;34(2):193-6. Similar results were found in studies conducted in the states of Minas Gerais, São Paulo, Paraná and Pernambuco.11 Lopes PD, Ramos EL, Gomez HC, Ferreira GL, Rezende OK. Prevalence of Chagas disease among blood donor candidates in Triangulo Mineiro, Minas Gerais State, Brazil. Rev Inst Med Trop Sao Paulo. 2015;57(6):461-5.,22 Ferreira JC, Costa PI, Buainain A, Rosa JA. Seropositivity for Chagas disease among blood donors in Araraquara São Paulo State, from 2004 to 2008. Rev Soc Bras Med Trop. 2011;44(1):110-2.,44 Melo AS, Lorena VM, Moraes AB, Pinto MB, Leão SC, Soares AK, et al. The prevalence of chagasic infection among blood donors in the State of Pernambuco Brazil. Braz J Hematol Hemother. 2009;31(2):69-73.,88 de Oliveira-Marques DS, Bonametti AM, Matsuo T, Gregori Junior F. The epidemiologic profile and prevalence of cardiopathy in Trypanosoma cruzi infected blood donor candidates, Londrina, Paraná, Brazil. Rev Inst Med Trop Sao Paulo. 2005;47(6):321-6.,1313 Sabino EC, Salles NA, Sarr M, Barreto AM, Oikawa M, Oliveira CD, et al. Enhanced classification of chagas serological results at 3 large blood centers in Brazil. Transfusion. 2010;50(12):2628-37. However, according to the National Health Foundation, there is no positive correlation between donor gender and reactive serology for the disease because it affects both men and women alike.33 Lima LM, Alves NP, Barbosa VD, Pimenta GA, Moraes-Souza H, Martins PR. Prevalence of Chagas disease in blood donors at the Uberaba Regional Blood Center Brazil, from 1995 to 2009. Rev Soc Bras Med Trop. 2012;45(6):723-6.,1515 Bonametti AM, Castelo Filho A, Ramos LR, Baldy JL, Matsuo T. Trypanosoma cruzi infection in blood donors. Rev Saude Publica. 1998;32(6):566-71.

However, other studies have shown that this predominance of the male gender is the result of cultural differences in the practice of blood donation, which is commonly attributed to men as excellent donors.11 Lopes PD, Ramos EL, Gomez HC, Ferreira GL, Rezende OK. Prevalence of Chagas disease among blood donor candidates in Triangulo Mineiro, Minas Gerais State, Brazil. Rev Inst Med Trop Sao Paulo. 2015;57(6):461-5.,44 Melo AS, Lorena VM, Moraes AB, Pinto MB, Leão SC, Soares AK, et al. The prevalence of chagasic infection among blood donors in the State of Pernambuco Brazil. Braz J Hematol Hemother. 2009;31(2):69-73. On the other hand, two studies showed that females presented a higher prevalence of T. cruzi reactivity that was directly associated with the habit of female farmers sleeping close to the clay walls of their homes, thus increasing exposure to triatomines.99 Silva FM, Pereira GA, Lages S, Moraes SH. Socioepidemiological screening of serologically ineligible blood donors due to Chagas disease for the definition of inconclusive cases. Mem Inst Oswaldo Cruz. 2010;105(6):800-5.,1717 Araújo AB, Vianna EE, Berne ME. Anti-Trypanosoma cruzi antibody detection in blood donors in the Southern Brazil. Braz J Infect Dis. 2008;12(6):480-2.

Another approach to the prevalence of chagasic infection in blood donors in the state of Pernambuco suggests that the reduction in infection levels in younger individuals is a reflection of the measures for vector control in the state.44 Melo AS, Lorena VM, Moraes AB, Pinto MB, Leão SC, Soares AK, et al. The prevalence of chagasic infection among blood donors in the State of Pernambuco Brazil. Braz J Hematol Hemother. 2009;31(2):69-73. Young donors are less infected because of vector control measures and older people stop to donate blood because of their age.

Some studies point to the fact that some of the contaminated individuals are rural farmers and probably contracted the infection directly from infected insects. However, it should be remembered that a large number of individuals in the urban zone are migrants from rural areas in search of a better life.77 Moura JF, Borges PJ, Costa J, Zauza PL, Rosa FM. On the possibility of autochthonous Chagas disease in Roraima, Amazon region, Brazil, 2000–2001. Rev Inst Med Trop S Paulo. 2005;47(1):45-4.,1212 Salles NA, Sabino EC, Barreto CC, Barreto AM, Otani MM, Chamone DF. The discarding of blood units and the prevalence of infectious diseases in donors at the Pro-Blood Foundation/Blood Center of São Paulo, São Paulo, Brazil. Rev Panam Salud Publica. 2003;13(2–3):111-6.

According to a study conducted in the state of Sao Paulo, the current T. cruzi prevalence in this region is probably due to two events: immigrant influx from endemic areas with vectorial transmission and the presence of residual undiagnosed asymptomatic cases before the eradication of the vectorial transmission. In recent years, due to the increased immigration of chronically infected individuals from endemic regions, an increase of the T. cruzi seroprevalence in non-endemic areas such as the state of São Paulo is expected.1616 Slavov SN, Otaguiri KK, Pinto MT, Valente VB, Ubiali EM, Covas DT, et al. Prevalence of Trypanosoma cruzi antibodies in blood donors from the Sao Paulo State Brazil, between 2012 and 2014. J Infect Dev Ctries. 2017;11(3):277-81.

Other aspects identified were the prevalence of low monthly family income and low level of schooling among blood donors infected with T. cruzi. Analysis of the studies revealed that people with Chagas disease are usually individuals with low professional qualifications and incomplete education who work in places that require more physical effort and do not offer good working conditions.55 Ferreira-Silva MM. Control of transfusional transmission. Rev Soc Bras Med Trop. 2011;44(Suppl. 2):64-7.,1818 Sabino EC, Lee TH, Montalvo L, Nguyen ML, Leiby DA, Carrick DM, et al. Antibody levels correlate with detection of Trypanosoma cruzi DNA by sensitive polymerase chain reaction assays in seropositive blood donors and possible resolution of infection over time. Transfusion. 2013;53(6):1257-65.

Nevertheless, there has been a great decrease in the occurrence of new cases of Chagas disease in recent decades. This was possibly due to epidemiological surveillance, improvement in income and housing conditions, the supply of electricity and access to education and healthcare. Although, these improvements were not as significant in the northern semi-arid region of the state of Minas Gerais, considered one of the poorest regions of Brazil, where the socioeconomic conditions of the local population are still precarious and of great concern, mainly in the rural zone. These conditions may account for the re-emergence of Chagas disease in this region, as its spatial distribution is coincident with that of poor populations and the disease is directly related to socioeconomic conditions.11 Lopes PD, Ramos EL, Gomez HC, Ferreira GL, Rezende OK. Prevalence of Chagas disease among blood donor candidates in Triangulo Mineiro, Minas Gerais State, Brazil. Rev Inst Med Trop Sao Paulo. 2015;57(6):461-5.,1919 Silva SM, Oliveira MB, Martinez EZ. Distribution of serological screening markers at a large hematology and hemotherapy center in Minas Gerais, Southeastern Brazil. Braz J Infect Dis. 2016;38(3):206-13.

Conclusion

In this study, the results found with the analysis of articles contribute to new reflections on this theme. The study showed that the risk factors associated with chagasic infection in the Brazilian population are quite heterogeneous. It also emphasized the need for the development of more specific and practical serological and confirmatory tests for the proper diagnosis of Chagas disease among blood donors thus eliminating inconclusive results. In addition, the evaluation of the literature allowed the identification of the epidemiological profile of blood donors in Brazil infected by T. cruzi, which is characterized in general by men, subjects older than 30, with a low level of schooling, low income and coming mainly from rural areas.

REFERENCES

  • 1
    Lopes PD, Ramos EL, Gomez HC, Ferreira GL, Rezende OK. Prevalence of Chagas disease among blood donor candidates in Triangulo Mineiro, Minas Gerais State, Brazil. Rev Inst Med Trop Sao Paulo. 2015;57(6):461-5.
  • 2
    Ferreira JC, Costa PI, Buainain A, Rosa JA. Seropositivity for Chagas disease among blood donors in Araraquara São Paulo State, from 2004 to 2008. Rev Soc Bras Med Trop. 2011;44(1):110-2.
  • 3
    Lima LM, Alves NP, Barbosa VD, Pimenta GA, Moraes-Souza H, Martins PR. Prevalence of Chagas disease in blood donors at the Uberaba Regional Blood Center Brazil, from 1995 to 2009. Rev Soc Bras Med Trop. 2012;45(6):723-6.
  • 4
    Melo AS, Lorena VM, Moraes AB, Pinto MB, Leão SC, Soares AK, et al. The prevalence of chagasic infection among blood donors in the State of Pernambuco Brazil. Braz J Hematol Hemother. 2009;31(2):69-73.
  • 5
    Ferreira-Silva MM. Control of transfusional transmission. Rev Soc Bras Med Trop. 2011;44(Suppl. 2):64-7.
  • 6
    Nascimento IC, Araújo MS, Brito MD, Oliveira JG. Care of the nursing team in the pediatric emergency: Integrative review. Sanare. 2017;16(1):90-9.
  • 7
    Moura JF, Borges PJ, Costa J, Zauza PL, Rosa FM. On the possibility of autochthonous Chagas disease in Roraima, Amazon region, Brazil, 2000–2001. Rev Inst Med Trop S Paulo. 2005;47(1):45-4.
  • 8
    de Oliveira-Marques DS, Bonametti AM, Matsuo T, Gregori Junior F. The epidemiologic profile and prevalence of cardiopathy in Trypanosoma cruzi infected blood donor candidates, Londrina, Paraná, Brazil. Rev Inst Med Trop Sao Paulo. 2005;47(6):321-6.
  • 9
    Silva FM, Pereira GA, Lages S, Moraes SH. Socioepidemiological screening of serologically ineligible blood donors due to Chagas disease for the definition of inconclusive cases. Mem Inst Oswaldo Cruz. 2010;105(6):800-5.
  • 10
    Silveira AC. New challenges and the future of control. Rev Soc Bras Med Trop. 2011;44(Suppl. 2):122-4.
  • 11
    Hamerschlak N, Pasternak J, Amato NV, de Carvalho MB, Guerra CS, Coscina AL, et al. Chagas’ disease: an algorithm for donor screening and positive donor counseling. Rev Soc Bras Med Trop. 1997;30(3):205-9.
  • 12
    Salles NA, Sabino EC, Barreto CC, Barreto AM, Otani MM, Chamone DF. The discarding of blood units and the prevalence of infectious diseases in donors at the Pro-Blood Foundation/Blood Center of São Paulo, São Paulo, Brazil. Rev Panam Salud Publica. 2003;13(2–3):111-6.
  • 13
    Sabino EC, Salles NA, Sarr M, Barreto AM, Oikawa M, Oliveira CD, et al. Enhanced classification of chagas serological results at 3 large blood centers in Brazil. Transfusion. 2010;50(12):2628-37.
  • 14
    Sobreira AC, Gomes FV, Silva MA, Oliveira MF. Chagasic infection prevalence in blood donors at the Regional Blood Donation Center of Iguatu. Rev Soc Bras Med Trop. 2001;34(2):193-6.
  • 15
    Bonametti AM, Castelo Filho A, Ramos LR, Baldy JL, Matsuo T. Trypanosoma cruzi infection in blood donors. Rev Saude Publica. 1998;32(6):566-71.
  • 16
    Slavov SN, Otaguiri KK, Pinto MT, Valente VB, Ubiali EM, Covas DT, et al. Prevalence of Trypanosoma cruzi antibodies in blood donors from the Sao Paulo State Brazil, between 2012 and 2014. J Infect Dev Ctries. 2017;11(3):277-81.
  • 17
    Araújo AB, Vianna EE, Berne ME. Anti-Trypanosoma cruzi antibody detection in blood donors in the Southern Brazil. Braz J Infect Dis. 2008;12(6):480-2.
  • 18
    Sabino EC, Lee TH, Montalvo L, Nguyen ML, Leiby DA, Carrick DM, et al. Antibody levels correlate with detection of Trypanosoma cruzi DNA by sensitive polymerase chain reaction assays in seropositive blood donors and possible resolution of infection over time. Transfusion. 2013;53(6):1257-65.
  • 19
    Silva SM, Oliveira MB, Martinez EZ. Distribution of serological screening markers at a large hematology and hemotherapy center in Minas Gerais, Southeastern Brazil. Braz J Infect Dis. 2016;38(3):206-13.

Publication Dates

  • Publication in this collection
    Jul-Sep 2018

History

  • Received
    29 Oct 2017
  • Accepted
    31 Jan 2018
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH) R. Dr. Diogo de Faria, 775 cj 133, 04037-002, São Paulo / SP - Brasil - São Paulo - SP - Brazil
E-mail: htct@abhh.org.br